You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

relapsed pediatric solid tumors

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumors, Brain Tumors Trial in Cincinnati (Amifostine)

Terminated
Has Results
  • Solid Tumors
  • Brain Tumors
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Dec 29, 2021

Relapsed Pediatric Solid Tumors, Refractory Pediatric Solid Tumors, Rhabdomyosarcoma Trial in Washington, Cincinnati (Magnetic

Active, not recruiting
  • Relapsed Pediatric Solid Tumors
  • +9 more
  • Magnetic Resonance High Intensity Focused Ultrasound
  • Washington, District of Columbia
  • +1 more
Jan 21, 2022

Solid Tumor Trial in Dallas (Atezolizumab, Vincristine, Irinotecan)

Not yet recruiting
  • Solid Tumor
  • Dallas, Texas
    The University of Texas Southwestern Medical Center
Aug 30, 2022

Refractory Ewing Sarcoma, Relapsed Ewing Sarcoma, Ewing Sarcoma Trial (Lurbinectedin)

Not yet recruiting
  • Refractory Ewing Sarcoma
  • +2 more
  • (no location specified)
Feb 15, 2023

Solid Tumors Trial run by the National Cancer Institute (NCI) (Nilotinib + Paclitaxel)

Recruiting
  • Solid Tumors
  • Nilotinib + Paclitaxel
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 24, 2022

Neuroblastoma Trial (Topotecan, Temozolomide, Ribociclib)

Not yet recruiting
  • Neuroblastoma
  • (no location specified)
Jun 17, 2022

Osteosarcoma, Ewing Sarcoma, Rhabdomyosarcoma Trial in Washington (Cryoablation Therapy, Nivolumab, Ipilimumab)

Recruiting
  • Osteosarcoma
  • +9 more
  • Cryoablation Therapy
  • +2 more
  • Washington, District of Columbia
    Children's National Hospital
Mar 21, 2022

Neuroblastoma, Neuroblastoma Recurrent, GD2-positive Solid Tumors Trial in Roma (GD2-CART01)

Recruiting
  • Neuroblastoma
  • +5 more
  • GD2-CART01
  • Roma, Italy
    Ospedale Pediatrico Bambino Gesù
Mar 9, 2022

Relapsed Solid Tumors, Refractory Solid Tumors, Relapsed Leukemia Trial in Canada, United States (Carfilzomib, Cyclophosphamide,

Recruiting
  • Relapsed Solid Tumors
  • +3 more
  • Phoenix, Arizona
  • +7 more
Apr 12, 2022

Primary Extra-cranial Solid Tumor, Recurrent or Refractory Glypican 3 (GPC3) Trial in New York, Cincinnati (Codrituzumab)

Recruiting
  • Primary Extra-cranial Solid Tumor
  • Recurrent or Refractory Glypican 3 (GPC3)
  • Los Angeles, California
  • +2 more
Oct 28, 2022

Solid Tumors Trial in United States (EZN-2208)

Terminated
  • Solid Tumors
  • Aurora, Colorado
  • +3 more
Jan 29, 2022

Solid Tumors, Primary Brain Tumors Trial in United States (Vincristine, Irinotecan, Temozolomide)

Completed
  • Solid Tumors
  • Primary Brain Tumors
  • Hartford, Connecticut
  • +13 more
Jan 12, 2023

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Hodgkin Lymphoma Trial in Madison (TCRaß+/CD19+ depleted Haploidentical

Recruiting
  • Acute Myeloid Leukemia
  • +10 more
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Mar 1, 2022

Pediatric Cancer, Solid Tumors, Rhabdomyosarcoma Trial in Washington (Magnetic resonance high intensity focused ultrasound,

Recruiting
  • Pediatric Cancer
  • +9 more
  • Magnetic resonance high intensity focused ultrasound
  • Lyso-thermosensitive liposomal doxorubicin
  • Washington, District of Columbia
    Children's National Medical Center
Dec 10, 2021

Refractory or Recurrent Solid Tumor Trial in France (Spartalizumab in Pediatric cohort, Low-dose Pazopanib in Pediatric Cohort,

Not yet recruiting
  • Refractory or Recurrent Solid Tumor
  • Spartalizumab in Pediatric cohort
  • +3 more
  • Angers, France
  • +8 more
Mar 9, 2022

Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Neuroblastoma Trial in Worldwide (Idasanutlin, Venetoclax,

Recruiting
  • Acute Myeloid Leukemia (AML)
  • +3 more
  • Phoenix, Arizona
  • +19 more
Jan 18, 2023

Cancer Trial in United States (Gemcitabine, Nab-paclitaxel)

Recruiting
  • Cancer
  • Aurora, Colorado
  • +3 more
Oct 28, 2021

Solid Tumor, Unspecified, Child, Relapsed Solid Tumor, CNS Tumor Trial in Worldwide (avapritinib)

Recruiting
  • Solid Tumor, Unspecified, Child
  • +2 more
  • Phoenix, Arizona
  • +12 more
Jul 19, 2022

Relapsed Solid Tumor, Refractory Solid Tumor, Relapsed CNS Tumor Trial in United States (cemiplimab (monotherapy), cemiplimab

Recruiting
  • Relapsed Solid Tumor
  • +5 more
  • cemiplimab (monotherapy)
  • +3 more
  • Los Angeles, California
  • +19 more
Jan 27, 2022

Pediatric Solid Tumor, Pediatric Lymphoma, Pediatric Brain Tumor Trial in Australia, Canada, United States (CLR 131)

Recruiting
  • Pediatric Solid Tumor
  • +7 more
  • CLR 131
  • Palo Alto, California
  • +6 more
Nov 30, 2021

Relapsed Solid Tumor, Refractory Solid Tumor Trial in Worldwide (Abemaciclib, Irinotecan, Temozolomide)

Recruiting
  • Relapsed Solid Tumor
  • Refractory Solid Tumor
  • Phoenix, Arizona
  • +28 more
Dec 7, 2022

Neuroblastoma, Rhabdomyosarcoma, Osteosarcoma Trial in United States (Enoblituzumab)

Completed
  • Neuroblastoma
  • +5 more
  • Palo Alto, California
  • +5 more
Feb 4, 2022

Recurrent Alveolar Rhabdomyosarcoma, Recurrent Ewing Sarcoma, Recurrent Lymphoma Trial in United States (Elimusertib)

Recruiting
  • Recurrent Alveolar Rhabdomyosarcoma
  • +7 more
  • Birmingham, Alabama
  • +28 more
Jan 26, 2023

Solid Tumor Trial in Cincinnati (Bevacizumab, Temozolomide, Vincristine)

Completed
  • Solid Tumor
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Feb 8, 2021

Refractory Solid Tumors Trial in Houston (Eribulin, Irinotecan, Temozolomide)

Recruiting
  • Refractory Solid Tumors
  • Houston, Texas
    M D Anderson Cancer Center
Aug 22, 2023